PMID: 11314933Apr 21, 2001Paper

Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?

Annals of Surgical Oncology
K M McMastersM J Edwards

Abstract

Sentinel lymph node (SLN) biopsy has become a standard method of staging patients with cutaneous melanoma. Sentinel lymph node biopsy usually is performed by intradermal injection of a vital blue dye (isosulfan blue) plus radioactive colloid (technetium sulfur colloid) around the site of the tumor. Intraoperative gamma probe detection has been shown to improve the rate of SLN identification compared to the use of blue dye alone. However, multiple sentinel nodes often are detected using the gamma probe. It is not clear whether these additional lymph nodes represent true sentinel nodes, or second-echelon lymph nodes that have received radiocolloid particles that have passed through the true sentinel node. This analysis was performed to determine the frequency with which these less radioactive lymph nodes contain metastatic disease when the most radioactive, or "hottest," node does not. In the Sunbelt Melanoma Trial, 1184 patients with cutaneous melanoma of Breslow thickness 1.0 mm or more had sentinel lymph nodes identified. Sentinel lymph node biopsy was performed by injection of technetium sulfur colloid plus isosulfan blue dye in 99% of cases. Intraoperative determination of the degree of radioactivity of sentinel nodes (ex vi...Continue Reading

References

Apr 1, 1992·Archives of Surgery·D L MortonA J Cochran
Sep 1, 1997·Plastic and Reconstructive Surgery·K E WellsD S Reintgen
Oct 1, 1998·The New England Journal of Medicine·D KragP Beitsch
Feb 25, 1999·Annals of Surgical Oncology·D L Morton, P J Bostick
Jul 14, 1999·Annals of Plastic Surgery·K E WellsD Reintgen
Aug 24, 1999·Annals of Surgical Oncology·S D Nathanson

❮ Previous
Next ❯

Citations

Dec 18, 2001·Journal of Surgical Oncology·M G TorchiaJ A Thliveris
Jan 21, 2009·European Journal of Nuclear Medicine and Molecular Imaging·A H ChakeraB Hesse
Aug 29, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Annette H ChakeraUNKNOWN European Association of Nuclear Medicine-European Organisation for Research and
Jul 13, 2011·Surgery Today·Hiroaki NomoriTakashi Nakayama
Apr 30, 2004·Current Treatment Options in Oncology·Stanley P L Leong
May 24, 2013·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Neil FairbairnMark Butterworth
Dec 13, 2000·American Journal of Surgery·M J EdwardsK M McMasters
Nov 27, 2001·American Journal of Surgery·E E ZervosW E Burak
Jun 25, 2004·Current Surgery·Marshall M Urist
Jan 3, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L KretschmerW Becker
Jun 13, 2001·Journal of the American College of Surgeons·S L WongK M McMasters
Feb 22, 2003·Journal of the American College of Surgeons·James S GoydosF Joseph Germino
Mar 7, 2002·Current Opinion in Oncology·Celia Chao, Kelly M McMasters
Feb 22, 2005·Clinical Nuclear Medicine·Stanley P L LeongMohammed Kashani-Sabet
Apr 25, 2006·Annals of Surgery·Charles R ScogginsUNKNOWN Sunbelt Melanoma Trial
Apr 2, 2009·Current Opinion in Otolaryngology & Head and Neck Surgery·Moni Abraham Kuriakose, Nirav P Trivedi
Dec 22, 2007·Clinical Nuclear Medicine·Peter BaptistaManuele Casale
Jan 29, 2009·World Journal of Surgical Oncology·Stephen P PovoskiEdward W Martin
Jan 7, 2003·Annals of Surgical Oncology·Celia ChaoUNKNOWN Sunbelt Melanoma Trial Group
Jul 4, 2003·Annals of Surgical Oncology·William R WrightsonUNKNOWN Sunbelt Melanoma Trial Study Group
Mar 3, 2004·Annals of Surgical Oncology·Celia ChaoKelly M McMasters
May 12, 2005·Annals of Surgical Oncology·Vivian S K YeeRoger F Uren
Aug 9, 2008·Annals of Surgical Oncology·Alice ChungLeslie Montgomery
Nov 4, 2008·Annals of Surgical Oncology·Charlotte AriyanDaniel Coit
Dec 8, 2009·Annals of Surgical Oncology·Charles R ScogginsKelly M McMasters
Jul 21, 2010·Annals of Surgical Oncology·Russell E BrownCharles R Scoggins
Oct 12, 2012·Annals of Surgical Oncology·Robert H I AndtbackaR Dirk Noyes
Aug 10, 2005·American Journal of Clinical Pathology·Laura E StewartRobin T Vollmer
Mar 21, 2002·The Lancet Oncology·K Fife, J F Thompson
Dec 3, 2013·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·A D MurphyB Powell
Feb 25, 2014·Clinical Nuclear Medicine·Gianpiero MancaGiuliano Mariani
Nov 11, 2006·Annals of Surgical Oncology·Cherie P ParungoJohn V Frangioni
Aug 26, 2014·Nuclear Medicine Communications·Gianpiero MancaGiuliano Mariani
Sep 24, 2014·The Surgical Clinics of North America·Charles W KimbroughEric G Davis
Mar 2, 2010·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Joachim KlodeCarsten Boeing
Jun 4, 2011·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Shelley A Sekula-Gibbs, Melissa A Shearer
Jul 21, 2004·Clinics in Dermatology·Anastasia PetroTimothy Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Richard J BleicherD L Morton
Plastic and Reconstructive Surgery
P Tulley, P E Butler
Archives of Otolaryngology--head & Neck Surgery
Cecelia E SchmalbachCarol R Bradford
© 2021 Meta ULC. All rights reserved